Ursodeoxycholic acid for the treatment of hepatic sarcoid: A pre-post pilot study [0.03%]
熊去氧胆酸治疗肝肉芽肿病的疗效观察：一项前后对照研究
Ethan Weinberg,Aimee Stonelake,Kelly Borges et al.
Ethan Weinberg et al.
Aim of the study: Sarcoidosis is characterized by noncaseating granulomas that can affect multiple organs. Due to the lack of prospective studies regarding treatment of hepatic sarcoidosis with ursodeoxycholic acid (UDCA)...
Comparison of intravenous terlipressin infusion versus bolus in patients with acute-on-chronic liver failure-acute kidney injury - an open label RCT [0.03%]
对比大剂量泰拉普利森与持续静脉滴注泰拉普利森治疗急性肝肾损伤的开放性随机对照试验
Tarana Gupta,Ashank Goel,Naveen Ranga et al.
Tarana Gupta et al.
Aim of the study: Despite having ample literature in hepatorenal syndrome-acute kidney injury (HRS-AKI) in decompensated cirrhosis patients, there is a scarcity of data on acute-on-chronic liver failure-acute kidney injur...
Methotrexate-induced hepatotoxicity in rats and the therapeutic properties of vitamin E: a histopathologic and flowcytometric research [0.03%]
甲氨蝶呤致大鼠肝毒性和维生素E的治疗作用：病理组织学和流式细胞仪研究
Ahmet U Akman,Zuleyha Erisgin,Sibel Turedi et al.
Ahmet U Akman et al.
Aim of the study: Methotrexate (MTX) causes oxidative stress-related liver damage. Our objective was to investigate the protective effects of vitamin E against MTX-induced hepatotoxicity through histopathological methods ...
Increased aminotransferases do not necessarily mean hepatotoxicity of CFTR modulator therapy [0.03%]
转氨酶升高并不一定意味着CFTR调节剂治疗导致了肝毒性
Marek Woynarowski,Ewa Sapiejka,Maria Jóźwiak et al.
Marek Woynarowski et al.
Aim of the study: The presence of macroenzymes may mimic treatment related hepatotoxicity. Material and methods: We present a female su...
The role of microRNAs in hepatocellular carcinoma: Therapeutic targeting of tumor suppressor and oncogenic genes [0.03%]
microRNA在肝细胞癌中的作用：抑癌基因与致癌基因的治疗靶向性研究
Nasim Rahimi Farsi,Bahman Naghipour,Parviz Shahabi et al.
Nasim Rahimi Farsi et al.
Hepatocellular carcinoma (HCC) is a severe malignant liver cancer with a poor prognosis and a high mortality rate. This carcinoma is a multistage process that begins with chronic hepatitis and progresses to cirrhosis, dysplastic nodules, an...
The influence of steroid therapy of complications of infectious mononucleosis on the course of Epstein-Barr virus hepatitis [0.03%]
糖皮质激素治疗传染性单核细胞增多症并发症对EB病毒性肝炎病程的影响
Magdalena Rutkowska,Maria Pokorska-Śpiewak
Magdalena Rutkowska
Aim of the study: The purpose of the study was to characterize the differences in the course of Epstein-Barr virus (EBV) primary infection-induced hepatitis between patients treated with steroids due to complications of i...
Porto-sinusoidal vascular disease: a new definition of an old clinical entity [0.03%]
porto-窦性血管病：一个旧临床实体的新定义
Mislav Barisic-Jaman,Marko Milosevic,Frane Pastrovic et al.
Mislav Barisic-Jaman et al.
Porto-sinusoidal vascular disease (PSVD) is defined as a vascular liver disease characterized by the absence of cirrhosis and the presence of characteristic histological features, with or without the presence of portal hypertension (PH). Ha...
Does amyloid β precursor protein gene expression have a role in diagnosis of biliary atresia? [0.03%]
淀粉样β前体蛋白基因表达在胆道闭锁诊断中有作用吗？
Salma Abdel Megeed Nagi,Heba Mohamed Abdallah,Abeer Abdelfattah El Gazzar et al.
Salma Abdel Megeed Nagi et al.
Aim of the study: Biliary atresia (BA) is an important cause of surgical jaundice. Although the precise etiology is unknown, β-amyloid (Aβ) has been observed around the bile ducts in BA livers. It is unclear whether Aβ...
N-acetylcysteine acts as a potent anti-inflammatory agent altering the eicosanoid profile in the development of simple steatosis and its progression to hepatitis [0.03%]
N-乙酰半胱氨酸通过改变二十烷酸谱来发挥强大的抗炎作用，从而影响肝脂肪变性的发生及其向肝炎进展的过程中所发生的事件
Klaudia Sztolsztener,Janusz Dzięcioł,Adrian Chabowski
Klaudia Sztolsztener
Aim of the study: We aimed to examine the influence of N-acetylcysteine (NAC) on the development of metabolic dysfunction-associated steatotic liver disease (MASLD) in rats with a specific focus on the eicosanoid pathway....
Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure [0.03%]
针对肾功能衰竭的HCV感染患者的基因型特异性及泛基因型直接抗病毒药物的真实世界有效性
Olga Tronina,Michał Brzdęk,Dorota Zarębska-Michaluk et al.
Olga Tronina et al.
Aim of the study: The aim is to summarize the effectiveness and safety of genotype-specific and pangenotypic hepatitis C virus (HCV) treatments in patients with renal failure. ...